Friday, 28 September 2018

FDA halts imports from China's Huahai after heart drug recall

The U.S. Food and Drug Administration said on Friday that it will no longer allow imports of drug ingredients or drugs made with ingredients produced by China's Zhejiang Huahai Pharmaceuticals, after a recall of one of its drugs that contained a probable carcinogen.


from Reuters: Health News https://ift.tt/2IoVTJR

No comments:

Post a Comment